Ratchaphruek Hospital PCLBKK:RPH-R 84 EV-to-EBIT is 10.42 as of Jul. 03, 2026, which is 46% below its 10-year median of 19.39. GuruFocus rates BKK:RPH-R with a GF Score™ of 84/100 and a GF Value™ of ฿5.96. The stock has 4 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Ratchaphruek Hospital PCL ranks better than 71.76% on this metric.
The historical rank and industry rank for Ratchaphruek Hospital PCL's EV-to-EBIT or its related term are showing as below:
BKK:RPH-R'
s EV-to-EBIT Range Over the Past 10 Years
Min: 4.26 Med: 19.39 Max: 49.76
Current: 10.42
During the past 13 years, the highest EV-to-EBIT of Ratchaphruek Hospital PCL was 49.76. The lowest was 4.26. And the median was 19.39.
BKK:RPH-R's EV-to-EBIT is ranked better than 71.76% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.78
vs BKK:RPH-R: 10.42
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ratchaphruek Hospital PCL's Enterprise Value for the quarter that ended in Mar. 2026 was ฿2,195 Mil.
Ratchaphruek Hospital PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿213 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ratchaphruek Hospital PCL EV-to-EBIT Related Terms
Ratchaphruek Hospital PCL EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ratchaphruek Hospital PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ratchaphruek Hospital PCL EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ratchaphruek Hospital PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ratchaphruek Hospital PCL's EV-to-EBIT falls into.
Ratchaphruek Hospital PCL's current Enterprise Value is ฿2,216 Mil.
Ratchaphruek Hospital PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿213 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ratchaphruek Hospital PCL (BKK:RPH-R) has a EV-to-EBIT of 10.42 as of Jul. 03, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ratchaphruek Hospital PCL and its competitors. This is 46% below median its historical median of 19.39. Over the past decade, Ratchaphruek Hospital PCL's EV-to-EBIT has ranged from 4.26 to 49.76. According to the industry distribution chart, Ratchaphruek Hospital PCL ranks #133 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 28.2%.
Is Ratchaphruek Hospital PCL's EV-to-EBIT too high?
Ratchaphruek Hospital PCL's current EV-to-EBIT of 10.42 is 46% below median its 10-year median of 19.39. Over the past 10 years, this metric has ranged from a low of 4.26 to a high of 49.76. The Healthcare Providers & Services industry median EV-to-EBIT is 15.78. Ratchaphruek Hospital PCL's value of 10.42 is 34% below this industry median. Based on the distribution chart, Ratchaphruek Hospital PCL ranks #133 out of 471 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ratchaphruek Hospital PCL has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Ratchaphruek Hospital PCL's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ratchaphruek Hospital PCL ranks #133 out of 471 companies for EV-to-EBIT. This puts Ratchaphruek Hospital PCL in the upper half of its industry. The industry median EV-to-EBIT is 15.78. Ratchaphruek Hospital PCL's value of 10.42 is 34% below this benchmark. Historically, Ratchaphruek Hospital PCL's own EV-to-EBIT has ranged from 4.26 to 49.76 over the past decade. While the company's 10-year median is 19.39 vs. the industry median of 15.78, Ratchaphruek Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.78, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ratchaphruek Hospital PCL's current EV-to-EBIT of 10.42 is 34% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ratchaphruek Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ratchaphruek Hospital PCL's current EV-to-EBIT is 10.42, which is 46% below median its own 10-year median of 19.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ratchaphruek Hospital PCL stock overvalued right now?
Ratchaphruek Hospital PCL (BKK:RPH-R) has a current EV-to-EBIT of 10.42. The stock's GF Value™ is ฿5.96, compared to a current price of ฿4.88 — trading 18.1% below its estimated fair value. The current EV-to-EBIT is 10.42, which is 46% below median its 10-year median of 19.39 and 34% below the Healthcare Providers & Services industry median of 15.78. Ratchaphruek Hospital PCL's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ratchaphruek Hospital PCL (BKK:RPH-R), the current EV-to-EBIT is 10.42 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ratchaphruek Hospital PCL (BKK:RPH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Ratchaphruek Hospital PCL stock appears to be undervalued.
The current stock price of ฿4.88 is trading 18.1% below its estimated GF Value™ of ฿5.96.
Key valuation signals for BKK:RPH-R:
EV-to-EBIT: 10.42 (46% below median its 10-year median of 19.39)
GF Value™: ฿5.96 vs. price of ฿4.88 (18.1% below fair value)
Industry Position: 34% below the Healthcare Providers & Services median (#133 of 471)
No single metric tells the full story. See the BKK:RPH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ratchaphruek Hospital PCL is engaged in the hospital business. It provides medical services comprising in-patient department, which derives maximum revenue, and out-patient departments. Some of the services include Surgery, Pediatric, Orthopedic, Obstetrics and Gynecology, and others. The company also operates in a single geographic area, which is Thailand.
84GF Score
Get the complete analysis for BKK:RPH-R
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RPH-R has been successfully added to your 
